Validity of World Health Organisation prescribing indicators in Namibia's primary healthcare: Findings and implications

International Journal for Quality in Health Care

Volumn 31, Issue 5, 2019, Pages 338-345

  Niaz, Q ^a   Godman, B ^b,c,d   Massele, A ^e   Campbell, S ^f,g   Kurdi, A ^c,h   Kagoya, H R ⁱ   Kibuule, D ^a  

^a UNIVERSITY OF NAMIBIA   (Namibia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^e UNIVERSITY OF BOTSWANA   (Botswana)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

^h HAWLER MEDICAL UNIVERSITY   (Iraq)

ⁱ Management Sciences for Health   (Namibia)

Author keywords

INRUD criteria; Namibia; Prescribing indicators; Primary healthcare; Validity

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; GENERIC DRUG;

ACCURACY; ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG INDICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMIBIA; OUTPATIENT CARE; PREDICTION; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VALIDITY; WORLD HEALTH ORGANIZATION; CLINICAL PRACTICE; PROCEDURES; PROTOCOL COMPLIANCE; QUESTIONNAIRE;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUGS, GENERIC; GUIDELINE ADHERENCE; HUMANS; NAMIBIA; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; SURVEYS AND QUESTIONNAIRES; WORLD HEALTH ORGANIZATION;

EID: 85066479632     PISSN: 13534505     EISSN: 14643677     Source Type: Journal    
DOI: 10.1093/intqhc/mzy172     Document Type: Article

References (46)

1. WHO. The World Medicines Situation. 2004. Available at URL: http:// apps.who.int/medicinedocs/en/d/Js6160e/.
2. Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015). BMC Public Health 2016;16:724.
3. Ofori-Asenso R, Agyeman AA. Irrational use of medicines-a summary of key concepts. Pharmacy 2016;4:35.
4. Cameron A, Ewen M, Ross-Degnan D et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009;373:240-9.
5. Ndishishi A. 'Namibia Demographic and Health Survey 2013.' Namibia Demographic and Health Survey 2013. Windhoek: Minsistry of Health and Social Services. Available at URL: http://catalog.ihsn.org/index.php/ catalog/5873/study-description.
6. WHO. Global Health Observatory. Raised blood pressure. 2014. Available at URL: http://www.who.int/gho/ncd/risk-factors/blood-pressure-prevalence-text/en/.
7. Kalemeera F, Cockeran M, Mubita M et al. The potential effect of using the Cockcroft-Gault method on Tenofovir-associated renal impairment reports and on clinical decisions regarding Tenofovir use in individual patients: implications for the future. J Infect Dis Prev Med 2017;5:170.
8. Nakwatumbah S, Kibuule D, Godman B et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia's national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther 2017;15:713-21.
9. WHO. How to investigate drug use in health facilities: Selected drug use indicators. Available at URL: http://apps.who.int/medicinedocs/en/d/ Js2289e/.
10. Holloway KA, Ivanovska V, Wagner AK et al. Have we improved use of medicines in developing and transitional countries and do we know how to Two decades of evidence. Trop Med Int Health 2013;18:656-64.
11. Kumar R, Indira K, Rizvi A et al. Antibiotic prescribing practices in primary and secondary health care facilities in Uttar Pradesh, India. J Clin Pharm Ther 2008;33:625-34.
12. Ogwal-Okeng JW, Obua C, Waako P et al. A comparison of prescribing practices between public and private sector physicians in Uganda. East Afr Med J 2004;Suppl:S12-6.
13. WHO. The Rational Use of Drugs-Report of the Conference of Experts Nairobi. Available at URL: http://apps.who.int/medicinedocs/documents/ s17054e/s17054e.pdf
14. MoHSS. National Pharmacy Management Information Systems (PMIS) Feedback report Apr-Sep 2015 National Pharmacy Management Information Systems (PMIS) Feedback report. Windhoek
15. Lates JA, Shiyandja N. Third National Survey on the Use of Drugs in Namibia's Public Health Institutions, Including Monitoring the Implementation of the National Drug Policy. Windhoek: Ministry of Health and Social Services, Namibia. 2001. Available at URL: http://www. google.co.uk/urlsa=t&rct=j&q=&esrc=s&source=web&cd=1&ved= 0ahUKEwiHmbv3zvPRAhVLL8AKHdWzCisQFggaMAA&url=http% 3A%2F%2Farchives.who.int%2Ficium%2Ficium2004%2Fresources% 2Fppt%2FAD022.ppt&usg=AFQjCNFrQn8kAWtrmzGNF9UXTEewUj0TVQ& bvm=bv.146094739,d.d2s.
16. Kunda M. An investigation of antibiotic prescribingin patients with upper respiratory tract infections (URTIs) at Katutura Health Centre. Windhoek: University of Namibia. 2014. Available at URL: http:// repository.unam.na/handle/11070/843.
17. Akpabio E, Sagwa E, Mazibuko G et al. (2014). Assessment of Compliance of Outpatient Prescribing with the Namibia Standard Treatment Guidelines in Public Sector Health Facilities, (March). Windhoek: MSH-Namibia
18. Oborne CA, Batty GM, Maskrey V et al. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997;43: 91-7.
19. Dyar OJ, Beovic B, Vlahovic-Palcevski V et al. How can we improve antibiotic prescribing in primary care Expert Rev Anti Infect Ther 2016;14: 403-13.
20. Godman B, Baker A, Leporowski A et al. Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context. Med Res Arch 2017;3:1-36.
21. MHRA UK. Antiepileptic drugs: new advice on switching between different manufacturers' products for a particular drug. Available at URL: https://www.gov.uk/drug-safety-update/antiepileptic-drugs-new-advice-onswitching-between-different-manufacturers-products-for-a-particular-drug.
22. Fadare JO, Adeoti AO, Desalu OO et al. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Rev Pharmacoecon Outcomes Res 2016;16:639-50.
23. Khan B, Godman B, Babar A et al. Assessment of active pharmaceutical ingredients in the registration procedures in Pakistan: implications for the future. GaBI J 2016;5:154-63.
24. Yin J, Wei X, Li H et al. Assessing the impact of general practitioner team service on perceived quality of care among patients with noncommunicable diseases in China: a natural experimental study. Int J Qual Health Care 2016;28:554-60.
25. Mansoor GF, Chikvaidze P, Varkey S et al. Quality of child healthcare at primary healthcare facilities: a national assessment of the Integrated Management of Childhood Illnesses in Afghanistan. Int J Qual Health Care 2017;29:55-62.
26. Larson E, Vail D, Mbaruku GM et al. Beyond utilization: measuring effective coverage of obstetric care along the quality cascade. Int J Qual Health Care 2017;29:104-10.
27. Edward A, Dam K, Chege J et al. Measuring pediatric quality of care in rural clinics-a multi-country assessment-Cambodia, Guatemala, Zambia and Kenya. Int J Qual Health Care 2016;28:586-93.
28. de Bie S, Kaguelidou F, Verhamme KM et al. Using Prescription Patterns in Primary Care to Derive New Quality Indicators for Childhood Community Antibiotic Prescribing. Pediatr Infect Dis J 2016;35:1317-23.
29. WHO. Antimicrobial Medicines Consumption (AMC) Network. 2017. Available at URL: http://www.euro.who.int/en/publications/abstracts/ antimicrobial-medicines-consumption-amc-network.-amc-data-20112014-2017.
30. MoHSS. Namibia Standard Treatment Guidelines (NSTG). Windhoek, Namibia: Ministry of Health and Social Services, 2012.
31. Kibuule D, Mubita M, Naikaku E et al. An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: findings and therapeutic implications. Int J Clin Pract 2017;71.
32. Namibia Statistics Agency. Namibia 2011 Population & Housing Census-Main Report. Windhoek. Available at URL: http://nsa.org.na/ microdata1/index.php/catalog/19/related-materials.
33. Kish And Leslie Sample Size Formula. Available at URL: http://www. pdfsdocuments2.com/k/28/kishand-leslie-sample-size-formula.pdf.
34. Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol 2004;5:11-8.
35. Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopi: a cross-sectional study. BMC Health Serv Res 2013;13:170.
36. Mashalla Y, Setlhare V, Massele A et al. Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: findings and implications. Int J Clin Pract 2017;71.
37. Olsson E, Wallach-Kildemoes H, Ahmed B et al. The influence of generic substitution on the content of patient-pharmacist communication in Swedish community pharmacies. Int J Phar Pract 2017;25:274-81.
38. Ntsekhe M, Hoohlo-Khotle N, Tlali M et al. Antibiotic Prescribing Patterns at Six Hospitals in Lesotho. Available at URL: http://apps.who. int/medicinedocs/en/d/Js21028en/.
39. Management Sciences for Health. MDS-3: Managing Access to Medicines and Health Technologies. Arlington VA: Management Sciences for Health, 2012. http://apps.who.int/medicinedocs/documents/s19577en/s19577en.pdf.
40. Campbell SM, Braspenning J, Hutchinson A et al. Research methods used in developing and applying quality indicators in primary care. BMJ 2003; 326:816-19.
41. Campbell SM, Kontopantelis E, Hannon KL et al. Framework and indicator testing protocol for developing and piloting quality indicators for the UK Quality and Outcomes Framework. BMC Fam Pract 2011;12:85.
42. Coenen S, Ferech M, Haaijer-Ruskamp FM et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 2007;16:440-5.
43. Adriaenssens N, Coenen S, Tonkin-Crine S et al. European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf 2011;20:764-72.
44. Nashilongo MM, Singu B, Kalemeera F et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther 2017;31:565-78.
45. Carey IM, Nightingale CM, DeWilde S et al. Blood pressure recording bias during a period when the Quality and Outcomes Framework was introduced. J Hum Hypertens 2009;23:764-70.
46. Godman B, Bishop I, Finlayson AE et al. Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Rev Pharmacoecon Outcomes Res 2013;13:469-8.